Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is on track to lose approximately $7.9 trillion worth of economic activity over the next ten years, regardless of the federal government’s astronomical stimulus spending in order to prop up the economy.

Although many restrictions across the US are being lifted and both consumers and businesses are slowly starting to recover, the financial effects of the coronavirus pandemic are most likely going to be felt well into fiscal 2030. The report estimates that real economic output will be reduced by at least 3% when compared to previous pre-pandemic estimates, meanwhile nominal GDP will see a reduction of 5.3% – which translates to approximately $15.7 trillion.

Furthermore, the CBO is anticipating GDP levels to drop by the most in US history in the second quarter of 2020, while the month of May will have an unemployment rate of approximately 20% – the highest since the Great Depression. As a result, Senator Chuck Schumer is calling on the Senate to approve another round of fiscal stimulus in order to mitigate the impending negative impacts on the economy.

Granada Gold Mine Inc. — sponsored Sponsored · Granada Gold Mine Inc.

Information for this briefing was found via CNBC and the Congressional Budget Office. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Meghan Markle’s Half-Brother Submitted Evidence Against Their Father, But Now Faces Philippine Police Scrutiny

Related News

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM

Commercial Bankruptcy Filings in the US Increase 48% Amid Coronavirus Pandemic

The coronavirus pandemic shocked the US economy, causing mandatory stay-at-home orders and businesses to temporarily...

Tuesday, June 9, 2020, 01:06:00 PM

US Jobless Claims Soaring Once Again: Is a Recession Closer Than It Appears?

The number of Americans filing for first time unemployment benefits is on the rise again,...

Friday, July 22, 2022, 11:23:00 AM

Datametrex To Sell Health Canada Approved COVID-19 Test Kits

Datametrex AI (TSXV: DM) announced this morning that it has obtained non-exclusive rights to a...

Monday, May 11, 2020, 10:56:16 AM

US Voters Becoming Increasingly Pessimistic On Economic Recovery, Success of Coronavirus Mitigation Measures

As the coronavirus pandemic continues to rage on in the US, American voters are growing...

Wednesday, July 8, 2020, 09:00:00 PM